Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 2020

View Archived Issues

Carbon dioxide and the brain

Researchers report identification of TQ-05310, a novel potent mutant IDH2 inhibitor

First-in-human data published for the pan-PIM kinase inhibitor PIM-447

Murine CD16.28z CAR iNKT cells exert both direct and indirect antitumor effects in vivo

Preliminary data from phase III ASCERTAIN study of ASTX-727

CohBar discovers novel peptide inhibitors of CXCR4

FDA clears IND for ADXS-504 as treatment of prostate cancer

Positive topline data from phase Ib study of CBP-201 in moderate to severe atopic dermatitis

Topline data from pivotal phase II portion of the ACTION-Galactosemia study

SR-4835, a novel CDK12/13 dual inhibitor for treating triple-negative breast cancer

Abbisko Therapeutics divulges FGFR-1 and/or FGFR-2 inhibitors

New treatment discovered for heart tissue scarring after infarct

Novartis presents new compounds for dengue

FDA clears Carmell's IND for pivotal study of BHA for open tibia fractures

Bone Biologics' rhNELL-1 growth factor promotes bone formation in preclinical study

Merck & Co. identifies new arginase inhibitors

ViiV Healthcare UK describes HIV integrase inhibitors

Eli Lilly and Company patents OGA inhibitors

Scynexis reports new phase III interim data with ibrexafungerp in invasive fungal infections

Blueprint releases topline data for pralsetinib in RET fusion-positive NSCLC

Agenus begins phase I study with bispecific antibody AGEN-1223

DBV reports data from open-label extension study of Viaskin Peanut

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...